MedPath

efficacy of a knee brace in patients after total knee endoprosthesis

Not Applicable
Recruiting
Conditions
Z96.65
Registration Number
DRKS00025166
Lead Sponsor
Bauerfeind AG
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
82
Inclusion Criteria

patients after total knee endoprosthesis operation (bicondylar/unicondylar)
- knee prosthesis: unilateral or bilateral, first operation or second operation (more than 6 month ago)
- age between 50 and 80 years
- OKS > 8
- patients have to be able to paticipate in this study kognitive and also physical
- patients have to be able to read and understand and sign the informed consent

Exclusion Criteria

- pregnancy, lactation or women who are planning a pregnancy during the time of the study
- patients with walking impairment/disability
- severe soft tissue hematoma
-patients who are not able to understand and sign the informed consent (not competent)
- severe and painful hematoma of the knee
- restriction of ROM
- impaired wound healing
- neurological impairment of mobility and gait stability
- impairments that makes it impossible to paticipate in this study

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The evaluation of the medical benefit of a knee brace will be estimated by the walking time of patients after their operation. The TWT (total walking time) will be measured by an analysis with a running course and is used to estimate the functional joint stability and reconvaliscence. The TWT will be measured at the beginning of rehabilitation, after 10 days and after 3 weeks.
Secondary Outcome Measures
NameTimeMethod
- oxford knee score<br>- pain reduction (VAS)<br>- reduction of medication use<br>- reduction of oedemas<br>- increase os ROM<br>- increase of knee stability<br>- walking distance<br>- gait parameters<br>- proprioception
© Copyright 2025. All Rights Reserved by MedPath